GSK Launches £450M Share Buyback Tranche, Part of £2B Program
Markets Daniel Marsh

GSK Launches £450M Share Buyback Tranche, Part of £2B Program

GSK has initiated a new £450 million share repurchase tranche, a component of its broader £2 billion capital return program. The company's shares edged higher ahead of the launch.

GSK
Computershare Shares Retreat on Ex-Dividend Date as Rate Outlook Lingers
Markets Daniel Marsh

Computershare Shares Retreat on Ex-Dividend Date as Rate Outlook Lingers

Computershare shares declined 3.47% on their ex-dividend date, partially reversing the prior session's gain. Investor focus remains on the interest rate outlook following the latest RBA commentary.

BHP ASX
CAR Group Shares Dip Amid RBA Uncertainty, Dividend Date Looms
Markets Daniel Marsh

CAR Group Shares Dip Amid RBA Uncertainty, Dividend Date Looms

CAR Group shares declined 0.54% to A$25.61 as the Reserve Bank of Australia's minutes provided no definitive interest rate guidance. Investors are now looking ahead to the March 13 ex-dividend date for the company's 42.5-cent interim payout.

CAR
PLS Group Gains Ahead of Interim Results, Eyes Lithium Contract Impact
Earnings James Calloway

PLS Group Gains Ahead of Interim Results, Eyes Lithium Contract Impact

PLS Group shares rose slightly ahead of its interim results release on Feb 19. The market is assessing the impact of a recent lithium offtake deal with Canmax Technologies.

Aristocrat Leisure Shares Hold Steady Ahead of Annual Meeting
Markets Daniel Marsh

Aristocrat Leisure Shares Hold Steady Ahead of Annual Meeting

Aristocrat Leisure shares edged up 0.04% to A$49.53 in Sydney trading, with investors awaiting management commentary at Thursday's annual meeting following recent volatility.

EWA
Treasury Wine Estates Plunges on Dividend Halt, Major US Write-Down
Earnings James Calloway

Treasury Wine Estates Plunges on Dividend Halt, Major US Write-Down

Treasury Wine Estates shares dropped 4.6% following its decision to pause dividend payments and post a substantial first-half net loss, driven by a major write-down in its US operations.

Zip Co Shares Rally Ahead of Key Half-Year Earnings Report
Earnings James Calloway

Zip Co Shares Rally Ahead of Key Half-Year Earnings Report

Zip Co shares advanced 2.8% to A$2.58 in Sydney trading, extending a two-session rally ahead of Thursday's half-year results. The buy-now-pay-later stock often experiences significant swings around earnings announcements.

ZIP
SEEK Shares Slide on China Write-Down, Employment Hero Exit Plan
Earnings James Calloway

SEEK Shares Slide on China Write-Down, Employment Hero Exit Plan

SEEK Ltd shares declined following a statutory loss driven by a significant write-down on its Zhaopin investment. The company tightened its full-year guidance and announced a record interim dividend.

ASX
Woolworths Shares Flat Ahead of Earnings, Regulatory Scrutiny Intensifies
Earnings James Calloway

Woolworths Shares Flat Ahead of Earnings, Regulatory Scrutiny Intensifies

Woolworths Group shares closed unchanged at A$31.96, with investor focus shifting to upcoming earnings and a potential regulatory lawsuit over discounting practices. The S&P/ASX 200 rose 0.24%.

EWA
Electro Optic Systems Surges 14% on Singapore Laser Hub Launch, Eyes Key Results
Technology Sarah Chen

Electro Optic Systems Surges 14% on Singapore Laser Hub Launch, Eyes Key Results

Electro Optic Systems Holdings Ltd saw its stock climb 13.7% to A$7.16 following the official opening of its high-energy laser weapon hub in Singapore. Investors await audited financial results expected around February 19.

EWS
Xero Shares Edge Lower on Melio Acquisition Share Issuance Filing
Technology Sarah Chen

Xero Shares Edge Lower on Melio Acquisition Share Issuance Filing

Xero's stock declined following a regulatory filing detailing new shares issued for the Melio acquisition. Investors are monitoring further share releases and the upcoming FY26 results in May.

XLK
Cochlear Shares Test Lows as Nexa Rollout Concerns Weigh on Outlook
Earnings James Calloway

Cochlear Shares Test Lows as Nexa Rollout Concerns Weigh on Outlook

Cochlear shares remain under pressure, trading close to a 52-week low as broker caution over the Nexa system rollout and currency headwinds cloud the company's near-term profit outlook.